Here we observed a widespread downregulation of GABPA expression in ccRCC and identified TGFBR2 as a direct target of GABPA through which the TGFβ signal was activated to inhibit ccRCC progression. The gene discussed is TGFBR2; the disease is nonpapillary renal cell carcinoma.